SCHEMBL4898207

SCHEMBL4898207

COc1cccc([C@@H](C)Nc2c(Nc3ccc4nccn4c3C)c(=O)c2=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 11/20 0.49
CCR6 P51684 1/20 0.42
IDH1 O75874 4/20 0.39
CXCR1 P25024 1/20 0.38
CXCR2 P25025 1/20 0.38
PLK1 P53350 2/20 0.38
ROCK1 Q13464 2/20 0.38
AURKB Q96GD4 2/20 0.38
DCLK1 O15075 1/20 0.38
ROCK2 O75116 1/20 0.38
CHEK2 O96017 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
IRAK1 P51617 1/20 0.38
PRKX P51817 1/20 0.38
NEK4 P51957 1/20 0.38
CSNK1G2 P78368 1/20 0.38
CDC42BPA Q5VT25 1/20 0.38
BRSK1 Q8TDC3 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903227 0.84 MAPKAPK2 (0.49) MAPKAPK2CCR6IDH1PLK1ROCK1
SCHEMBL4905183 0.76 MAPKAPK2 (0.54) MAPKAPK2IDH1PLK1ROCK1AURKB
SCHEMBL4543440 0.74 MAPKAPK2 (0.72) MAPKAPK2PLK1ROCK1AURKBDCLK1
SCHEMBL4599142 0.73 MAPKAPK2 (0.53) MAPKAPK2IDH1PLK1ROCK1AURKB
SCHEMBL4919825 0.72 MAPKAPK2 (0.54) MAPKAPK2CCR6CXCR1CXCR2PLK1
SCHEMBL4905505 0.71 CXCR2 (0.41) MAPKAPK2CXCR2ROCK1AURKBROCK2
SCHEMBL4914806 0.69 MAPKAPK2 (0.55) MAPKAPK2CCR6PLK1ROCK1AURKB
SCHEMBL4915911 0.69 MAPKAPK2 (0.55) MAPKAPK2CCR6PLK1ROCK1AURKB
SCHEMBL4362293 0.69 MAPKAPK2 (0.68) MAPKAPK2PLK1ROCK1AURKBDCLK1
SCHEMBL4905771 0.69 MAPKAPK2 (0.55) MAPKAPK2PLK1ROCK1AURKBDCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 MAPKAPK2 346/4885CCR6 3339/4885IDH1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.